IRCT201609105563N8
Recruiting
Phase 2
Comparison of suppressive hormonal therapy(LD tablet) with aspiration in regression of ovarian endometrioma
Vice chancellor for Research,Tabriz University Of Medical Sciences0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Endometriosis of ovary.
- Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •womens aged 15\-45; unilateral endometrioma, endometrioma diagnosis with ultrasound; CA 125\<100; mass size less than or equal to 6 cm
- •Exclusion criteria:
- •the possibility of malignancy; contraindications of LD pill; ischemic heart disease or previous history of it; current breast cancer; liver tumors (benign and malignant))
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the effectiveness of platelet-rich plasma in the treatment of Asherman's syndromeAsherman syndrome.Intrauterine synechiaeN85.6IRCT20200316046789N1Esfahan University of Medical Sciences60
Unknown
Not Applicable
Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot FlashesHot FlashesNight SweatsNCT00547001Hartford Hospital235
Completed
Phase 3
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric statesIRCT138809032766N1Tarbiat Maodares University150
Active, not recruiting
Not Applicable
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI
Active, not recruiting
Not Applicable
Effets du traitement hormonal substitutif et du raloxifène sur les cellules dendritiques plasmacytoïdes et les lymphocytes B chez les femmes ménopausées - EstrimmuneEUCTR2009-017144-14-FRCentre Hospitalier de Toulouse